G8 ups commitments to Africa
At Gleneagles last year the G8 agreed to a further set of measures to reduce poverty and support sustainable development in Africa. The Southern Times has compiled the following report on funds disbursed or to be disbursed by members of G8:
l Canada will contribute C$450 million between 2006-2016 to support country-led efforts to strengthen health systems and improve health outcomes in Africa.
Canada is ready to contribute C$100 million to support an Advance Market Commitments pilot project to develop a vaccine for pneumococcal disease.
l Canada will contribute C$250 million in 2006 to the Global Fund to Fight Aids, Tuberculosis and Malaria (Global Fund) to support 2006-07 activities. Canada has committed C$800 million to support efforts to fight HIV/AIDS since 2000. Other recent Canadian initiatives include C$160 million for the Global Alliance for Vaccines and Immunisation (GAVI), C$62 million to the International Aids Vaccine Initiative and C$5 million to the African Aids Vaccine Programme. Canada has also committed C$15 million to the International Partnership for Microbicides.
The European Commission.
l Since the Creation of the Global Fund in 2001 the EC will have contributed ‘ 522 million by the end of 2006, with ‘ 90 million allocated in 2006 alone.
In 2002-2006, the EC will have spent ‘ 420 million on research targeted at the three main communicable diseases – HIV/AIDS, malaria and tuberculosis a four-fold increase in comparison to the previous four-year period.
l The European Commission pledged ‘100 million at the Beijing Conference in January 2006 to confront avian influenza and prepare for a possible human pandemic, with additional ‘111 million pledged by the EU Member States. ‘ 20 million of European Commission’s pledge is targeted to support of scientific research projects, with a further ‘ 80 million devoted to assistance projects.
l As regards polio eradication, the European Commission has provided ‘ 61 million to finance supplementary immunisation activities in countries with endemic transmission ‘ Nigeria, Niger and Somalia.
l France will spend ‘ 1,4 billion for the period 2006-2008 for multilateral actions related to the fight against emerging and transmissible diseases.
l Regarding innovative financing, France has launched an air ticket solidarity contribution, which so far 17 countries expressed their intention to endorse. At least 90 percent of the proceeds of this contribution (estimated to around ‘ 200 million a year), which is effective from 1 July, will finance an international drug purchase facility-UNITAID, aimed at ensuring an uninterrupted supply of pre-qualified products at reduced price for beneficiary countries.
l Germany is actively engaged in prevention and control of infectious diseases in developing countries.
The German government annually spends ‘ 300 million on prevention and control of HIV/AIDS, malaria and tuberculosis and health system development. Germany ranks fifth in the international bilateral donor community on combating polio and has committed ‘ 39 million of new bilateral funds.
For efforts to fight Avian Influenza, Germany has committed approximately ‘ 40 million for bilateral programs in Asia and Africa, for vaccine development and for support for a global crises-reaction-mechanism.
With ‘ 800 million is the largest donor for bilateral water projects which is a very important pillar in fighting infectious diseases.
l Germany is also promoting research into treatments that are of special interest to developing countries.
l Italy has put forward a market-based mechanism to foster research and development of new vaccines against infectious diseases that mostly hit poor countries: Advance Market Commitment (AMC).
Together with GAVI and the World Bank, a pilot project has been developed that can be launched in 2006.
l Italy is also actively participating in the financing of several multilateral/ bilateral initiatives fighting Malaria, Polio, Tuberculosis, Avian flu and other infectious diseases.
l Italy will provide 600million USD to the IFFim over 20 years and contribute 460 million euros to Global Fund in the period 2004-2007.
l Japan launched the ‘Health and Development’ Initiative in June 2005 aiming to provide up to US$ 5 billion over five years from 2005 to 2009 to combat infectious diseases and other threats to health in the developing countries, out of which more than US$ 620 million has been disbursed during the fiscal year 2005.
l In June 2005, Japan pledged to contribute US$ 500 million to the Global Fund in the coming years, and contributed US$ 130 million to the Fund in March 2006 as the first step to fulfil this commitment.
l To combat avian and human pandemic influenza, Japan pledged US$ 155 million on the occasion of the International Pledging Conference on Avian and Human Pandemic Influenza held in January 2006 in Beijing, and has disbursed the full amount
l Russia and the World Bank agreed to collaborate in developing a debt-for-development swap for channelling $250 million freed-up from debt service to high priority development actions in Sub-Saharan Africa.
In some of these HIPC eligible countries, the World Bank is developing important projects and programs in support of country strategies to fight infectious diseases.
l Russia will join forces with the World Bank in the fight against malaria in Sub-Saharan Africa, and will support the World Bank-led malaria booster program that aims to achieve tangible results by 2010. Besides that Russia and the World Bank agreed to expand their cooperation in Central Asia to meet the challenge of infectious diseases.
l In 2005, Russia has doubled up to $40 millions its pledge to the Global Fund. Russia also intends to reimburse to the Global Fund until 2010 nearly US$270 million, which would be distributed to fund projects in Russian Federation.
l The UK is committed to the achievement of the objectives set at Gleneagles, including universal access to drugs against HIV/Aids by 2010. The UK is committed to spend ‘1.5 billion on HIV/AIDS from 2005/06 to 2007/08 and will contribute ‘360 million to the Global Fund between 2002 and 2008. The UK also supports innovative financing mechanisms: it will provide ‘1.4 billion over 20 years to the IFFIm to tackle preventable diseases, and has announced that it is prepared to make a long-term financial contribution to the IDPF-UNITAID.
l The UK is prepared to make a long-term financial contribution to pilot AMC. It supports the launch of a Pneumococcus AMC by the end of 2006 and believes that a Malaria AMC should be explored.
l The UK also funds seven product development public private partnerships, which carry out research into new drugs, vaccines and microbicides for tackling communicable diseases. The UK is providing ’60 million between 2006 and 2008 towards the cost of eradicating polio.
l The United States will provide $15 billion over 5 years to support international HIV/Aids programmes.
l The US will contribute $90 million in fiscal year 2006 to bilateral tuberculosis programs in over 35 countries.
l The US will increase funding for malaria prevention and treatment by more than $1.2 billion over 5 years.
l The US has provided nearly 25 percent of Global Polio Eradication Initiative funding; has pledged $362 million for countries to prepare for, detect, and rapidly respond to outbreaks of highly pathogenic avian influenza. ‘ G8 Documents.